ORGANIC ANION TRANSPORT AND ACTION OF GAMMA-GLUTAMYL-TRANSPEPTIDASE IN KIDNEY LINKED MECHANISTICALLY TO RENAL TUBULAR UPTAKE OF INORGANIC MERCURY

被引:62
作者
ZALUPS, RK
机构
[1] Division of Basic Medical Sciences, Mercer University School of Medicine, Macon
关键词
D O I
10.1006/taap.1995.1110
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
In the present Study, the roles of renal tubular gamma-glutamyl transpeptidase and renal organic anion transport on the renal uptake and accumulation and intrarenal distribution of injected inorganic mercury were investigated. The renal (and general) disposition of injected inorganic mercury (Hg2+) was evaluated in control rats, rats pretreated with two 10 mg/kg doses of acivicin, rats pretreated with a 10 mmol/kg dose of p-aminohippurate (PAH), and rats pretreated with both acivicin and PAH. The dose(s) of acivicin were used to inhibit the activity of renal gamma-glutamyl transpeptidase to a near maximal level and the dose of PAH (which is a water-soluble organic anion) was used to competitively inhibit the renal organic anion transport system to a near maximal level. Dispositional data were obtained at both 1 and 24 hr after a nontoxic, 0.5 mu mol/kg iv dose of mercuric chloride had been administered. Radiolabeled inorganic mercury (Hg-203(2+)) was added to the injection solution containing the mercuric chloride to make it possible to quantitate the accumulation and disposition of mercury using standard isotopic methods. The renal concentration and content of mercury were significantly lower in the rats pretreated with either acivicin or PAH than in the control rats at both times after the injection of inorganic mercury. Pretreatment with acivicin mainly affected the content of mercury in the renal cortex, while pretreatment with PAH affected the content of mercury in both the renal cortex and the outer stripe of the outer medulla. Interestingly, the renal concentration and content of mercury in the rats pretreated with both acivicin and PAH were significantly lower than in any of the other three groups at both times after injection of inorganic mercury. Evaluation of the intrarenal distribution of mercury indicated that the renal cortex was the main zone in which the uptake of mercury was significantly affected by both acivicin and PAW. The findings from this study indicate that the renal tubular uptake of administered inorganic mercury is linked both to the transport of organic anions and to the action of gamma-glutamyltransferase. Thus, at least two mechanisms appear to be involved in the renal tubular uptake of inorganic mercury. (C) 1995 Academic Press, Inc.
引用
收藏
页码:289 / 298
页数:10
相关论文
共 21 条
[1]   PROBENECID-INDUCED PROTECTION AGAINST ACUTE HEXACHLORO-1,3-BUTADIENE AND METHYL MERCURY TOXICITY TO THE MOUSE KIDNEY [J].
BAN, M ;
DECEAURRIZ, J .
TOXICOLOGY LETTERS, 1988, 40 (01) :71-76
[2]   EVIDENCE FOR ACTIVE DIPEPTIDE TRANSPORT IN ISOLATED PROXIMAL STRAIGHT TUBULES [J].
BARFUSS, DW ;
GANAPATHY, V ;
LEIBACH, FH .
AMERICAN JOURNAL OF PHYSIOLOGY, 1988, 255 (01) :F177-F181
[3]   RENAL GLUTATHIONE AND MERCURY UPTAKE BY KIDNEY [J].
BERNDT, WO ;
BAGGETT, JM ;
BLACKER, A ;
HOUSER, M .
FUNDAMENTAL AND APPLIED TOXICOLOGY, 1985, 5 (05) :832-839
[4]   ROLE OF EXTRACELLULAR GLUTATHIONE AND GAMMA-GLUTAMYL-TRANSPEPTIDASE IN THE DISPOSITION AND KIDNEY TOXICITY OF INORGANIC MERCURY IN RATS [J].
DECEAURRIZ, J ;
PAYAN, JP ;
MOREL, G ;
BRONDEAU, MT .
JOURNAL OF APPLIED TOXICOLOGY, 1994, 14 (03) :201-206
[5]   DISTRIBUTION OF OXIDIZED AND REDUCED FORMS OF GLUTATHIONE AND CYSTEINE IN RAT PLASMA [J].
LASH, LH ;
JONES, DP .
ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS, 1985, 240 (02) :583-592
[6]  
LASH LH, 1989, J PHARMACOL EXP THER, V248, P531
[7]   TRANSPORT OF GLUTATHIONE BY RENAL BASAL-LATERAL MEMBRANE-VESICLES [J].
LASH, LH ;
JONES, DP .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1983, 112 (01) :55-60
[8]  
LASH LH, 1984, J BIOL CHEM, V259, P4508
[9]  
LASH LH, 1985, MOL PHARMACOL, V28, P278
[10]   POSSIBLE ROLE OF HEPATIC GLUTATHIONE IN TRANSPORT OF METHYLMERCURY INTO MOUSE KIDNEY [J].
NAGANUMA, A ;
ODAURANO, N ;
TANAKA, T ;
IMURA, N .
BIOCHEMICAL PHARMACOLOGY, 1988, 37 (02) :291-296